Immunology

Deficient immune cells implicated in TB disease progression

Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB.  Credit: NIAID

Nearly a quarter of the world’s population is estimated to be infected with Mycobacterium tuberculosis (M.tb), the pathogen that causes tuberculosis, but less than 15 percent of infected individuals develop the disease.

A study published May 24 in Nature Immunology by investigators from Harvard Medical School, Brigham and Women’s Hospital, and the Broad Institute of MIT and Harvard offers insights into the immune system that may help explain why some people have latent infections and others get sick.

In collaboration with Socios En Salud, (a part of Partners In Health based in Peru), researchers looked at a type of immune cell called memory T cells from 259 Peruvian individuals who were participating in a long-term program to monitor the progression of TB in people who were found to have latent infections.

The study leveraged high-dimensional single-cell data with new computational techniques to define key cell states for TB progression

By integrating single-cell RNA and surface protein data from more than 500,000 memory T cells, researchers defined 31 cell states and identified a key T cell type, Th17, that may be deficient in many individuals who progress to active TB. This study implicated Th17 function as a potential component of preventing TB progression.

“We are hopeful that the strategies used will help us in the future to identify high-risk individuals for TB, and point the way to the kinds of vaccines and other immunomodulatories that might prevent TB,” said corresponding author Soumya Raychaudhuri, professor of medicine at HMS and Brigham and Women’s and professor of biomedical informatics at HMS.

“This study is exciting not only because of the large-scale single-cell genomic tools that we use, but because it is one of the only studies of its kind in infectious disease,” Raychaudhuri said.

Raychaudhuri is also director of the Center for Data Sciences at Brigham and Women’s and an institute member at the Broad.

The study is the latest result of a long-term collaboration between HMS researchers and the health care delivery nongovernmental organization Socios En Salud, led by Megan Murray, the Ronda Stryker and William Johnston Professor of Global Health in the Blavatnik Institute at HMS and D. Branch Moody, HMS professor of medicine at Brigham and Women’s, both co-authors the new study. Murray’s work in Peru has centered around the epidemiology and genetics of tuberculosis.

Murray’s collaboration with Raychaudhuri’s team includes a previous study reported in Nature Communications in 2019 that analyzed how a given individual’s genetics impact their chances of becoming infected or ill with TB and identified a gene associated with TB progression, as well as a study that identified the single largest genetic contributor to height known to date.

Additional co-authors from HMS, Brigham and Women’s, the Broad, Socios En Salud, La Jolla Institute for Immunology, University of California San Francisco, Universidade Federal do Rio de Janeiro, Utrecht University, and the University of Manchester also contributed to this study.


Researchers identify most powerful gene variant for height known to date


More information:
Aparna Nathan et al, Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment and disease, Nature Immunology (2021). DOI: 10.1038/s41590-021-00933-1

Citation:
Deficient immune cells implicated in TB disease progression (2021, June 4)
retrieved 4 June 2021
from https://medicalxpress.com/news/2021-06-deficient-immune-cells-implicated-tb.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.